| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/24/2011 | US20110045583 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 02/24/2011 | US20110045574 Chromatography medium |
| 02/24/2011 | US20110045572 Protein variants having modified immunogenicity |
| 02/24/2011 | US20110045538 Peptide, Use Of The Peptide, Method For The Production Of The Peptide, Solid Support Having The Peptide Immobilized Thereon, And Method For Production Of The Solid Support |
| 02/24/2011 | US20110045537 Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors |
| 02/24/2011 | US20110045536 Mammalian expression vector |
| 02/24/2011 | US20110045534 Nucleic Acid Cassette For Producing Recombinant Antibodies |
| 02/24/2011 | US20110045509 Method For Determining The Type of an Inflammatory-Rheumatic Disease in Synovial Fluid |
| 02/24/2011 | US20110045495 Composition and method for diagnosis or detection of renal cancer |
| 02/24/2011 | US20110045491 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
| 02/24/2011 | US20110045020 Nucleic acid comprising chimeric gene derived from hepatitis c virus |
| 02/24/2011 | US20110045018 Astrovirus species |
| 02/24/2011 | US20110045017 Hiv vaccine for mucosal delivery |
| 02/24/2011 | US20110045008 Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110045003 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| 02/24/2011 | US20110045002 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044998 Stabilized Angiopoietin-2 Antibodies And Uses Thereof |
| 02/24/2011 | US20110044996 Neutralizing antibodies |
| 02/24/2011 | US20110044995 Anti-hiv monoclonal antibody |
| 02/24/2011 | US20110044994 Human immunodeficiency virus (hiv)-neutralizing antibodies |
| 02/24/2011 | US20110044990 Antibody design using anti-lipid antibody crystal structures |
| 02/24/2011 | US20110044988 Methods of treatment using anti-mif antibodies |
| 02/24/2011 | US20110044987 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 02/24/2011 | US20110044986 Anti-amyloid antibodies and uses thereof |
| 02/24/2011 | US20110044984 Monoclonal Antibody Capable of Binding to Anexelekto, and Use Thereof |
| 02/24/2011 | US20110044982 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 02/24/2011 | US20110044980 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 02/24/2011 | US20110044979 Domain antibody construct |
| 02/24/2011 | US20110044978 Method for treating bone fracture |
| 02/24/2011 | US20110044976 Humanized antibodies |
| 02/24/2011 | US20110044975 Treatment of prion protein related diseases |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044931 Multi-conjugate of sirna and preparing method thereof |
| 02/24/2011 | US20110044902 Modulation of the Immune Response |
| 02/24/2011 | US20110044896 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof |
| 02/24/2011 | US20110044894 Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof |
| 02/24/2011 | US20110044893 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 02/24/2011 | US20110042260 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 02/24/2011 | DE112008003232T5 Antigen-Bindungskonstrukte Antigen-binding constructs |
| 02/24/2011 | CA2772111A1 Novel agents and uses thereof |
| 02/24/2011 | CA2771465A1 Variant immunoglobulins with improved manufacturability |
| 02/24/2011 | CA2771441A1 Antibodies for the detection of integrin complexes in ffpe material |
| 02/24/2011 | CA2771436A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 02/24/2011 | CA2771277A1 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility |
| 02/24/2011 | CA2769998A1 Imatinib immunoassay |
| 02/24/2011 | CA2769619A1 Targeted immunoconjugates |
| 02/24/2011 | CA2769427A1 Anti-cmet antibody and its use for the detection and the diagnosis of cancer |
| 02/24/2011 | CA2769407A1 Mimotopes of hiv and uses thereof |
| 02/23/2011 | EP2287607A1 Method for quantification of antigen-specific canine or human ige |
| 02/23/2011 | EP2287337A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 02/23/2011 | EP2287316A1 Antigenic polypeptides |
| 02/23/2011 | EP2287315A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287314A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287313A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287312A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287311A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287310A1 Compositions and methods of use for mgd-csf in disease treatment |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287202A1 Anti-sialic acid antibody molecules |
| 02/23/2011 | EP2287201A2 RS7 antibodies |
| 02/23/2011 | EP2287200A1 Method for generating monoclonal antibodies that recognize progenitor cells |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287197A1 Anti-cMET antibody and its use for the detection and the diagnosis of cancer |
| 02/23/2011 | EP2287196A2 Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases |
| 02/23/2011 | EP2287195A2 Pan-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy |
| 02/23/2011 | EP2287194A2 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth |
| 02/23/2011 | EP2287193A1 Antibody molecules having specificity for human IL-1 beta |
| 02/23/2011 | EP2287192A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287190A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287189A1 Small Streptococcus pyogenes antigens and their use |
| 02/23/2011 | EP2287188A1 Small Streptococcus pyogenes antigens and their use |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2287182A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287181A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287177A2 Streptococcus agalactiae antigens I + II |
| 02/23/2011 | EP2287175A2 Novel chemokine binding peptides capable of modulating the biological activity of chemokines |
| 02/23/2011 | EP2286844A2 Antibody-drug conjugates and methods |
| 02/23/2011 | EP2286830A2 Composition comprising vlp and amyloid-beta peptide |
| 02/23/2011 | EP2286240A1 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 02/23/2011 | EP2286231A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3 |
| 02/23/2011 | EP2285989A2 Novel targets for regulation of angiogenesis |
| 02/23/2011 | EP2285833A1 AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME |
| 02/23/2011 | EP2285832A2 Antibodies and processes for preparing the same |
| 02/23/2011 | EP2285831A2 Reagents, methods, and systems for detecting methicillin-resistant staphylococcus |
| 02/23/2011 | EP2285830A1 Purification process for antibody fragments using derivatized triazines as affinity ligands |
| 02/23/2011 | EP2285409A1 Il-1 alpha abs and methods of use |
| 02/23/2011 | EP2285408A2 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
| 02/23/2011 | EP2285404A1 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose |
| 02/23/2011 | EP2079482B1 Use of an anti-cd151 antibody in the treatment of primary cancer |
| 02/23/2011 | EP1831257B1 Humanized antibody specific for tumor necrosis factor-alpha |
| 02/23/2011 | EP1791868B1 Antibodies binding to receptors kir2dl1, -2, 3 but not kir2ds4 and their therapeutic use |
| 02/23/2011 | EP1766411B1 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 02/23/2011 | EP1135504B1 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 02/23/2011 | EP0972024B1 A tumor suppressor designated ts10q23.3 |
| 02/23/2011 | CN101981452A Method for detection of pneumococcus |
| 02/23/2011 | CN101981187A Partial peptide of Survivin presented on MHC class II molecule and use thereof |